Viewing StudyNCT06454448



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06454448
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2024-06-06

Brief Title: Phase IbII Clinical Study of Adebrelimab in Combination With Decitabine Albumin-bound Paclitaxel and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization: Tianjin Medical University Cancer Institute and Hospital

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-06-15
Start Date Type: ACTUAL
Primary Completion Date: 2025-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-11
Completion Date Type: ESTIMATED
First Submit Date: 2024-06-06
First Submit QC Date: June 6 2024
Study First Post Date: 2024-06-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-26
Last Update Post Date: 2024-06-28
Last Update Post Date Type: ACTUAL